Check out our most popular compounded medications! Get Started
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded suppository containing lactobacillus acidophilus, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing lactobacillus acidophilus is listed. Products containing it are filed in the directory as unapproved drugs and homeopathic products, in capsule, liquid and cream forms. None of the listed products containing lactobacillus acidophilus is in suppository form.
Suppository bases differ, and the base used decides how USP <795> classifies the preparation for beyond-use dating. The date printed on the label is the one to follow.
Lactobacillus acidophilus is a probiotic bacterium, not a drug, that compounding pharmacies include in oral capsules and vaginal preparations by prescription.
Lactobacillus acidophilus is a rod-shaped, Gram-positive lactic acid bacterium that normally lives in the human digestive tract and female genital tract, and it is the Lactobacillus species most often used in commercial probiotic products. Probiotics are live microorganisms intended to have a health benefit when consumed or applied to the body. There is no FDA-approved drug containing Lactobacillus acidophilus. FDA regulates a probiotic as a dietary supplement, a food ingredient or a drug depending on its intended use; supplements do not need FDA approval before marketing, and FDA has stated it "has not approved any probiotic product for use as a drug or biological product in infants of any age." Prescribers may order it compounded for a specific strain count in a capsule or a vaginal form without retail-supplement fillers. Compounded preparations are not FDA-approved and require a prescription.
Because no FDA-approved drug exists, there is no prescribing label or boxed warning. NCCIH notes that risk of harm is greater in people with serious illness or weakened immune systems, that possible harms include infection, transfer of antibiotic-resistance genes and unlisted contaminants, and that few studies have examined safety in detail. FDA has warned that live bacterial products given to hospitalized preterm infants have caused serious invasive infections, including a death in 2023. Reviews of lactobacilli flag caution in the elderly and the immunocompromised, and note that effects are strain-specific. Ask your prescriber or pharmacist before use if you are pregnant or nursing. If you develop fever, bloating that persists or signs of infection, stop and talk to your prescriber or pharmacist.
Lactobacillus acidophilus is an obligate homofermentative lactobacillus that produces lactic acid from carbohydrates. Proposed probiotic mechanisms, reviewed in Advances in Nutrition (2019), include competitive exclusion of pathogens, bacteriocin production, short-chain fatty acid production, support of mucin production and epithelial barrier function, bile salt metabolism and immunomodulation toward regulatory T cells and IL-10; a 2022 Frontiers in Immunology review reports in vitro and animal data for specific L. acidophilus strains (beta-defensin-2 induction, reduced H. pylori viability and adhesion, reduced IL-8) and stresses that findings cannot be assumed to apply across strains. There are no labeled indications. NCCIH summarizes research as promising but inconclusive for antibiotic-associated diarrhea, infant colic, periodontal disease and ulcerative colitis, with unclear strain, dose and population; the Frontiers review reports mixed randomized trials of L. acidophilus as an adjunct to H. pylori eradication. Strain, count and route are per prescriber. Lactobacilli hold GRAS status in the US. Not a controlled substance.
Wash your hands. If the suppository is soft, chill it in its wrapper in the refrigerator or under cool water for a few minutes, then unwrap it. For rectal use, coat the tip with a water-soluble lubricant (not petroleum jelly), lie on your side with your upper knee bent, and insert it pointed end first past the muscle at the opening. For vaginal use, lie on your back with knees bent and insert it as far as it comfortably goes, by finger or applicator; bedtime use limits leakage, and a panty liner protects clothing. Stay lying down about 15 minutes. Wash your hands.
Suppositories are nonaqueous, so under USP <795> they can carry a beyond-use date of up to 180 days at controlled room temperature or in the refrigerator when no other stability data apply. Storage depends on the base: fatty bases can soften at room temperature and may be labeled for the refrigerator, while polyethylene glycol bases usually do not need refrigeration. Keep them cool so they do not melt, and refrigerate them if your label says to.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository
